Marcel Rozencweig
Fondatore presso Neotx Holdings Ltd.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Irina Staatz-Granzer | M | 64 | 15 anni | |
| Roger Kornberg | M | 76 |
Neotx Holdings Ltd.
 Neotx Holdings Ltd. Pharmaceuticals: MajorHealth Technology Neotx Holdings Ltd. develops oncology drugs. The company was founded by Marcel Rozencweig, Robert Harow and Asher Nathan in 2014 and is headquartered in Rehovot, Israel. | 4 anni |
| Robert Harow | M | - |
Neotx Holdings Ltd.
Neotx Holdings Ltd. Pharmaceuticals: MajorHealth Technology Neotx Holdings Ltd. develops oncology drugs. The company was founded by Marcel Rozencweig, Robert Harow and Asher Nathan in 2014 and is headquartered in Rehovot, Israel. | 9 anni |
| Olivier Martinez | M | 54 | 14 anni | |
| Asher Nathan | M | - |
Neotx Holdings Ltd.
Neotx Holdings Ltd. Pharmaceuticals: MajorHealth Technology Neotx Holdings Ltd. develops oncology drugs. The company was founded by Marcel Rozencweig, Robert Harow and Asher Nathan in 2014 and is headquartered in Rehovot, Israel. | - |
| Véronique Chabernaud | M | 62 | 9 anni | |
| James Hill | M | 75 |
Neotx Holdings Ltd.
Neotx Holdings Ltd. Pharmaceuticals: MajorHealth Technology Neotx Holdings Ltd. develops oncology drugs. The company was founded by Marcel Rozencweig, Robert Harow and Asher Nathan in 2014 and is headquartered in Rehovot, Israel. | 4 anni |
| Scott Fields | M | 69 |
Neotx Holdings Ltd.
Neotx Holdings Ltd. Pharmaceuticals: MajorHealth Technology Neotx Holdings Ltd. develops oncology drugs. The company was founded by Marcel Rozencweig, Robert Harow and Asher Nathan in 2014 and is headquartered in Rehovot, Israel. | - |
| Paul Marinelli | M | 56 |
Neotx Holdings Ltd.
Neotx Holdings Ltd. Pharmaceuticals: MajorHealth Technology Neotx Holdings Ltd. develops oncology drugs. The company was founded by Marcel Rozencweig, Robert Harow and Asher Nathan in 2014 and is headquartered in Rehovot, Israel. | 4 anni |
| Odile Laurent | F | 63 | 7 anni | |
| Seo-Yong Cho | M | 55 |
Neotx Holdings Ltd.
Neotx Holdings Ltd. Pharmaceuticals: MajorHealth Technology Neotx Holdings Ltd. develops oncology drugs. The company was founded by Marcel Rozencweig, Robert Harow and Asher Nathan in 2014 and is headquartered in Rehovot, Israel. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Pierre F. Dodion | M | 69 | 6 anni | |
| François Romagné | M | 60 | 14 anni | |
| Philippe Pouletty | M | 65 | 15 anni | |
| Hemanshu Shah | M | 63 |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | 7 anni |
| Stéphane Boissel | M | 56 | 8 anni | |
| Patrick J. Langlois | M | 78 | 12 anni | |
| Ekaterina Smirnyagina | M | 58 | - | |
| Maïlys Ferrère | F | 60 | 4 anni | |
| Michael A. Caligiuri | M | 68 | - | |
| Nicolai Wagtmann | M | 60 | 3 anni | |
| Thomas J. McKearn | M | 75 |
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | - |
| Mondher Mahjoubi | M | 65 | 8 anni | |
| Lars Fruergaard Jorgensen | M | 58 | 6 anni | |
| Anne-Sophie Herelle | F | 43 | - | |
| Catherine Moukheibir | F | 64 | 5 anni | |
| Per Gunnar Falk | M | - | - | |
| Jeno Gyuris | M | 64 |
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | 9 anni |
| Martine George | M | 76 |
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | 3 anni |
| Frank Morich | M | 69 | 6 anni | |
| Jean Deleage | M | 83 | 9 anni | |
| Terje Kalland | M | 73 | 3 anni | |
| Thomas E. Needham | M | 60 |
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | - |
| Alison Taunton-Rigby | M | 80 |
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | 2 anni |
| Frank Bulens | M | 61 | 9 anni | |
| Jean-Charles Soria | M | 53 | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Francia | 24 | 66.67% |
| Israele | 7 | 19.44% |
| Stati Uniti | 6 | 16.67% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Marcel Rozencweig
- Contatti personali
